Showing results (1501-1510 of 3,156) with videos related to

Sort By:
Pageof 316
Neuro-Oncology|January 13, 2026
ON-01, an engineered recombinant oncolytic herpes simplex virus type-1, in recurrent glioma: a single-arm, phase 1/2 studyWei Zeng, Peiwen Wang, Sheng Fang, et al.
Neuro-Oncology|January 15, 2026
KMT2A is a prerequisite of malignant transformation during IDH-mutant gliomagenesisMarilin S Koch, Minh Deo, Claudia Schmidt, et al.
Neuro-Oncology|January 31, 2026
A brief history of ependymomaDavid R Ghasemi, Denise Obrecht-Sturm, Kimberly M Wallgren, et al.
Neuro-Oncology|January 31, 2026
Distinct tumor immune microenvironmental (TIME) landscapes drive divergent immunotherapy responses in glioblastomaLinqian Weng, Krish Skandha Gopalan, Mélanie Guyot, et al.
Neuro-Oncology|February 3, 2026
Meningioma microenvironment harbors a rich immune landscape that evolves with biological stateXiaopeng Guo, Zachary A Moynihan, Joseph Driver, et al.
Neuro-Oncology|February 6, 2026
Neurofibromatosis type 1 plexiform neurofibromas: Integrating treatment across pediatric and adult populationsAmy E Armstrong, Andrea M Gross, Laura J Klesse, et al.
Neuro-Oncology|February 2, 2026
Beyond base camp: PI3K/mTOR inhibition for the treatment of pediatric high-grade gliomasRyan J Duchatel, Clara Savary, Zacary P Germon, et al.
Neuro-Oncology|January 25, 2026
Cognitive Function, Quality of Life, and Survival Outcomes in Patients with Lower Grade Gliomas Treated with Proton Radiation Therapy: A Phase II studyJason M Slater, Nora K Horick, Lisa B Nachtigall, et al.
Neuro-Oncology|February 4, 2026
Preclinical efficacy of combinatorial B7-H3 CAR T cells and ONC206 against diffuse intrinsic pontine gliomaAndrea Timpanaro, Edward Z Song, Ryma Toumi, et al.
Neuro-Oncology|February 11, 2026
The prognostic impact of CDKN2A/B hemizygous deletions in meningiomaFranziska M Ippen, Thomas Hielscher, Areeba Patel, et al.
Pageof 316